How should an early-stage B2B SaaS founder balance product stability with sales velocity while converting trial users and building industry credibility?

Question

Accepted Answer

Hi,

Welcome to Wisen - glad you're here. And this is an interesting question for a very specific reason that I've never written about before; My father's first entrepreneurial business - that he started when he was in his late twenties - was a chemical importing business. So he would have been a great client (but a family business competitor!).

Anyway . . . to your questions:

Your first question is easy: your go to market should be as aggressive as you can make it right now. Don’t hide until the product is “stable.” Although some revenue would be nice, the real reason you need to get that product out there is so that you speed up the rate of learning. So do everything you can to get it in front of users, but be brutally honest: “This is early. I’ll work closely with you. In return, I need feedback and a paid pilot.” In B2B, especially traditional industries, service-led is not a compromise. It’s how you learn what the software must become.

I'm not suggesting that you go all in on one or the other (go-to-market or stability), but that you simply switch the ratio to 80/20.

For trial conversion, stop selling “insights.” Sell outcomes: avoided loss, better buying timing, margin protection. Ask each trial user: “What decisions that we help you make would make this worth $X per month?” Then build around that. Charge early, even modestly. Free users are often polite liars.

For credibility, become the person explaining this niche better than anyone else. Post weekly chemical supply-chain breakdowns, event-to-price case studies, and “what we’re watching” notes. Don’t market broadly. Teach narrowly.

And being niche is not a problem. Vague is a problem. If ChemRisk Pro helps one trader make one better call, that’s real value.

Finally: Speed matters, yes. But learning speed beats coding speed.